Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined ...
PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for March 2025 of $0.08 per share, payable on April 1, 2025 to stockholders of record as of March 14, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback